| Lastest Insider Transactions Of SUPERNUS PHARMACEUTICALS, INC. ( SUPN ) |
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-21 | Sell | 14,491 | 35.31 | 511,677 | 2024-03-25 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-21 | Option Exercise | 14,491 | 25.30 | 366,622 | 2024-03-25 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-20 | Sell | 400 | 35.31 | 14,124 | 2024-03-22 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-20 | Option Exercise | 400 | 25.30 | 10,120 | 2024-03-22 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-19 | Sell | 12,364 | 35.31 | 436,573 | 2024-03-21 17:01:05 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-19 | Option Exercise | 12,364 | 25.30 | 312,809 | 2024-03-21 17:01:05 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-13 | Sell | 62,366 | 33.74 | 2,104,289 | 2024-03-15 18:39:08 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-13 | Option Exercise | 62,366 | 17.61 | 1,098,523 | 2024-03-15 18:39:08 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-12 | Sell | 3,884 | 32.99 | 128,133 | 2024-03-14 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-03-12 | Option Exercise | 3,884 | 12.98 | 50,414 | 2024-03-14 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2024-02-28 | Option Exercise | 990 | 0.00 | 0 | 2024-02-29 17:01:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2024-02-28 | Option Exercise | 35,000 | 0.00 | 0 | 2024-02-29 17:00:51 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-02-26 | Sell | 5,000 | 30.21 | 151,050 | 2024-02-28 17:01:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2024-02-26 | Option Exercise | 5,000 | 9.13 | 45,650 | 2024-02-28 17:01:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2024-01-10 | Sell | 8,000 | 27.91 | 223,280 | 2024-01-12 17:00:24 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2024-01-10 | Option Exercise | 8,000 | 9.24 | 73,920 | 2024-01-12 17:00:24 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | Sr. VP, Chief Medical Officer | 2023-12-22 | Option Exercise | 600 | 0.00 | 0 | 2023-12-26 17:01:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-12-22 | Option Exercise | 25,000 | 0.00 | 0 | 2023-12-26 17:00:28 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2023-11-16 | Sell | 2,500 | 28.01 | 70,025 | 2023-11-20 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2023-11-16 | Option Exercise | 7,457 | 9.24 | 68,903 | 2023-11-20 17:00:07 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-11-15 | Sell | 9,093 | 28.50 | 259,151 | 2023-11-17 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-11-15 | Option Exercise | 7,457 | 9.24 | 68,903 | 2023-11-17 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-11-14 | Sell | 1,110 | 28.13 | 31,224 | 2023-11-16 17:00:06 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-11-14 | Option Exercise | 2,000 | 9.24 | 18,480 | 2023-11-16 17:00:06 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-10-13 | Option Exercise | 4,000 | 0.00 | 0 | 2023-10-13 17:00:09 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-09-07 | Option Exercise | 2,500 | 0.00 | 0 | 2023-09-07 17:00:26 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-09-07 | Option Exercise | 35,000 | 0.00 | 0 | 2023-09-07 17:00:14 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-30 | Sell | 8,100 | 32.00 | 259,200 | 2023-09-01 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-30 | Option Exercise | 8,100 | 23.99 | 194,319 | 2023-09-01 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-08-25 | Sell | 5,135 | 31.59 | 162,215 | 2023-08-29 17:00:48 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-05-11 | Option Exercise | 1,500 | 0.00 | 0 | 2023-05-12 17:00:45 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-05-11 | Option Exercise | 31,250 | 0.00 | 0 | 2023-05-12 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-05-11 | Option Exercise | 750 | 0.00 | 0 | 2023-05-12 17:00:20 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | DEC TIMOTHY C | Senior Vice-President & CFO | 2023-03-14 | Option Exercise | 1,500 | 0.00 | 0 | 2023-04-10 17:00:35 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-03-14 | Option Exercise | 20,000 | 0.00 | 0 | 2023-04-10 17:00:30 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | Sr VP, Quality, GMP Oper. & IT | 2023-03-14 | Sell | 4,780 | 35.99 | 172,023 | 2023-03-16 17:00:55 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Mottola Frank | SVP, Quality, GMP, Ops, IT | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:35:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Martin Tami Tillotson | Sr. V.P., Regulatory Affairs | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:01:54 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Rubin Jonathan | SVP, Chief Medical Officer | 2023-02-16 | Option Exercise | 1,500 | 0.00 | 0 | 2023-02-21 17:01:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-02 | Sell | 13,732 | 42.05 | 577,492 | 2023-02-06 17:01:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-02 | Option Exercise | 22,845 | 9.56 | 218,398 | 2023-02-06 17:01:04 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-01 | Sell | 300 | 42.01 | 12,602 | 2023-02-03 17:00:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-02-01 | Option Exercise | 498 | 9.56 | 4,761 | 2023-02-03 17:00:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-31 | Sell | 976 | 42.01 | 41,002 | 2023-02-02 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-31 | Option Exercise | 1,620 | 9.56 | 15,487 | 2023-02-02 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-18 | Sell | 4,936 | 40.40 | 199,394 | 2023-01-20 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-18 | Option Exercise | 8,080 | 9.56 | 77,245 | 2023-01-20 17:00:22 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-17 | Sell | 4,826 | 39.92 | 192,638 | 2023-01-19 17:00:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-17 | Option Exercise | 4,826 | 9.13 | 44,061 | 2023-01-19 17:00:53 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-17 | Sell | 25,446 | 40.03 | 1,018,728 | 2023-01-19 17:00:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2023-01-17 | Option Exercise | 41,920 | 9.56 | 400,755 | 2023-01-19 17:00:46 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-03-14 | Option Exercise | 40,000 | 0.00 | 0 | 2023-01-13 17:00:58 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Hudson Frederick M. | Directior | 2023-01-10 | Option Exercise | 8,722 | 7.90 | 68,904 | 2023-01-12 17:00:38 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-06 | Sell | 174 | 39.90 | 6,943 | 2023-01-09 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Bhatt Padmanabh P. | Sr. VP of IP, CSO | 2023-01-06 | Option Exercise | 174 | 9.13 | 1,589 | 2023-01-09 17:00:40 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | NEWHALL CHARLES W III | Directior | 2022-12-28 | Option Exercise | 8,722 | 7.90 | 68,904 | 2022-12-30 17:01:49 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-12-20 | Sell | 15,360 | 38.11 | 585,387 | 2022-12-22 17:00:56 |
| SUPN | SUPERNUS PHARMACEUTICALS, INC. | Khattar Jack A. | President, CEO | 2022-12-20 | Option Exercise | 25,000 | 9.56 | 239,000 | 2022-12-22 17:00:56 |
